FindTrial
Sign In

Effect of co_administration of vitamins A and D in patients with pneumosepsis

Effect of co_administration of vitamins A and D on inflammatory cytokines of TNF-alfa and Intl-17 in patients with pneumosepsis: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130424013110N6
Enrollment
44
Registered
2019-08-22
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumosepsis. Other sepsis

Interventions

Intervention 1: Intervention group: First (intervention) group receive, 300000 unit vitamin D (1 milliliter), Intramuscular (IM) with 50000 unit vitamin A (1 milliliter), Intramuscular (IM) as a singl

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18 to 80 years old Patients satisfaction Hospitalized for at least 3 days

Exclusion criteria

Exclusion criteria: Unwillingness to cooperate Not using Vitamin D supplements before intervention In the last three months Pregnancy

Design outcomes

Primary

MeasureTime frame
Cytokine of TNF-alfa. Timepoint: Before and 72 hours after the intervention. Method of measurement: ELISA Kit.;Interleukin 17. Timepoint: Before and 72 hours after the intervention. Method of measurement: ELISA Kit.;Serum Vitamin D level. Timepoint: Before and 72 hours after the intervention. Method of measurement: mg/dl.;Serum Vitamin A level. Timepoint: Before and 72 hours after the intervention. Method of measurement: mg/dl.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Abolfazl Jokar

Arak University of Medical Sciences

dr.a.jokar@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026